Description: The peptide sequence YGRKKRRQRRRYKEGYNVYG is a fusion construct combining the HIV-1 TAT protein transduction domain (PTD) with a regulatory motif derived from the GluA2 subunit of AMPA receptors. This chimeric peptide is commonly referred to as TAT-GluA2₃Y and is designed to facilitate cellular uptake while modulating synaptic receptor dynamics. Functional Overview TAT Domain (YGRKKRRQRRR) : This segment is a well-characterized cell-penetrating peptide (CPP) derived from the HIV-1 transactivator of transcription (TAT) protein. It enables the translocation of various molecular cargoes across cellular membranes, primarily through interactions with negatively charged cell surface components and subsequent endocytic pathways . GluA2₃Y Motif (YKEGYNVYG) : This sequence corresponds to a tyrosine-rich domain of the GluA2 subunit of AMPA receptors. Phosphorylation of this motif is implicated in the endocytosis of GluA2-containing AMPA receptors, a process critical for synaptic plasticity mechanisms such as long-term depression (LTD) . Combined Functionality : The fusion of the TAT domain with the GluA2₃Y motif allows the peptide to enter neurons efficiently and interfere with the endocytosis of GluA2-containing AMPA receptors. By inhibiting this internalization, the peptide can modulate synaptic strength and plasticity. Applications in Neuroscience Research Synaptic Plasticity Studies : TAT-GluA2₃Y is utilized to investigate the role of AMPA receptor trafficking in synaptic plasticity, learning, and memory. Behavioral Neuroscience : By modulating AMPA receptor dynamics, the peptide serves as a tool to study behavioral outcomes associated with altered synaptic transmission, such as in models of addiction or fear conditioning. Therapeutic Potential : Understanding and controlling AMPA receptor endocytosis has implications for developing treatments for neurological disorders where synaptic dysfunction is a hallmark. Considerations Specificity : While the TAT domain facilitates broad cellular uptake, it lacks cell-type specificity, which may lead to off-target effects. Stability : Peptides can be susceptible to proteolytic degradation; thus, modifications may be necessary to enhance stability for in vivo applications. Dosage and Delivery : Optimal concentrations and delivery methods need to be established to achieve desired effects without toxicity. The YGRKKRRQRRRYKEGYNVYG peptide, or TAT-GluA2₃Y, is a valuable research tool that combines efficient cellular delivery with the ability to modulate AMPA receptor endocytosis. Its applications span from basic neuroscience research to potential therapeutic strategies targeting synaptic dysfunction. | The peptide sequence YGRKKRRQRRRYKEGYNVYG is a fusion construct combining the HIV-1 TAT protein transduction domain (PTD) with a regulatory motif derived from the GluA2 subunit of AMPA receptors. This chimeric peptide is commonly referred to as TAT-GluA2₃Y and is designed to facilitate cellular uptake while modulating synaptic receptor dynamics. Functional Overview -
TAT Domain (YGRKKRRQRRR): This segment is a well-characterized cell-penetrating peptide (CPP) derived from the HIV-1 transactivator of transcription (TAT) protein. It enables the translocation of various molecular cargoes across cellular membranes, primarily through interactions with negatively charged cell surface components and subsequent endocytic pathways . -
GluA2₃Y Motif (YKEGYNVYG): This sequence corresponds to a tyrosine-rich domain of the GluA2 subunit of AMPA receptors. Phosphorylation of this motif is implicated in the endocytosis of GluA2-containing AMPA receptors, a process critical for synaptic plasticity mechanisms such as long-term depression (LTD) . -
Combined Functionality: The fusion of the TAT domain with the GluA2₃Y motif allows the peptide to enter neurons efficiently and interfere with the endocytosis of GluA2-containing AMPA receptors. By inhibiting this internalization, the peptide can modulate synaptic strength and plasticity. Applications in Neuroscience Research -
Synaptic Plasticity Studies: TAT-GluA2₃Y is utilized to investigate the role of AMPA receptor trafficking in synaptic plasticity, learning, and memory. -
Behavioral Neuroscience: By modulating AMPA receptor dynamics, the peptide serves as a tool to study behavioral outcomes associated with altered synaptic transmission, such as in models of addiction or fear conditioning. -
Therapeutic Potential: Understanding and controlling AMPA receptor endocytosis has implications for developing treatments for neurological disorders where synaptic dysfunction is a hallmark. Considerations -
Specificity: While the TAT domain facilitates broad cellular uptake, it lacks cell-type specificity, which may lead to off-target effects. -
Stability: Peptides can be susceptible to proteolytic degradation; thus, modifications may be necessary to enhance stability for in vivo applications. -
Dosage and Delivery: Optimal concentrations and delivery methods need to be established to achieve desired effects without toxicity. The YGRKKRRQRRRYKEGYNVYG peptide, or TAT-GluA2₃Y, is a valuable research tool that combines efficient cellular delivery with the ability to modulate AMPA receptor endocytosis. Its applications span from basic neuroscience research to potential therapeutic strategies targeting synaptic dysfunction. |
Scientific Background | YGRKKRRQRRRYKEGYNVYG is a 20-residue synthetic peptide with the sequence Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Tyr-Lys-Glu-Gly-Tyr-Asn-Val-Tyr-Gly. The sequence contains 3 Lys and 6 Arg residues, contributing cationic character; contains 4 aromatic residues that can contribute to hydrophobic or aromatic interactions. These sequence-derived properties describe the reagent chemically; no specific receptor, enzyme, pathway, disease association, or biological activity is assigned without product-specific experimental evidence. |
Experimental Notes | Sequence-derived chemical properties support reagent selection and experimental planning but do not establish biological function. Solubility, aggregation, adsorption, conjugation efficiency, and assay performance should be validated under the intended experimental conditions. |
